| Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease (NCT01233960) | Mesoblast, Inc. | 2010-11-29 |
| Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease (NCT01224171) | Millennium Pharmaceuticals, Inc. | 2010-11-01 |
| Special Investigation in Patients With Crohn's Disease (All Patients Investigation) (NCT01298648) | AbbVie (prior sponsor, Abbott) | 2010-11-01 |
| Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease (NCT01279577) | Dr. Falk Pharma GmbH | 2010-11-01 |
| Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease (NCT01094613) | Teva GTC | 2010-11-01 |
| A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence (NCT01190839) | Janssen Biotech, Inc. | 2010-11-01 |
| Early Postoperative Recurrence in Crohn's Disease: Predictors of Research Targeting the Constitutional Mutation of IRGM (NCT01663142) | Centre Hospitalier Universitaire de Nice | 2010-10-01 |
| Green Tea in Crohn's Disease (NCT01231217) | University Hospital Heidelberg | 2010-10-01 |
| Prognostic Indicators as Provided by the EPIC ClearView (NCT01476995) | Epic Research & Diagnostics, Inc. | 2010-09-01 |
| PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease (NCT01155362) | Celularity Incorporated | 2010-08-01 |
| Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol (NCT01190410) | UCB Pharma | 2010-08-01 |
| Japanese Phase I of GSK1605786 (NCT01611805) | GlaxoSmithKline | 2010-07-22 |
| Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease (NCT02319798) | Manchester University NHS Foundation Trust | 2010-07-01 |
| Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease (NCT01144962) | Leiden University Medical Center | 2010-06-01 |
| Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease (NCT01244386) | University College Cork | 2010-06-01 |
| Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use (NCT00968721) | Vanderbilt University | 2010-06-01 |
| Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in Crohn's Disease (CD) (NCT01105741) | Martin Storr | 2010-06-01 |
| A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects (NCT01114607) | GlaxoSmithKline | 2010-05-05 |
| Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD) (NCT01289366) | University of Erlangen-Nürnberg Medical School | 2010-05-01 |
| Laquinimod Phase IIa Study in Active Crohn's Disease (NCT00737932) | Teva Branded Pharmaceutical Products R&D, Inc. | 2010-05-01 |
| Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's Fistula (NCT01314079) | Anterogen Co., Ltd. | 2010-04-01 |
| GWA Study in Patients With Inflammatory Bowel Disease (NCT01140789) | Chinese University of Hong Kong | 2010-04-01 |
| An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066) (NCT00988832) | Merck Sharp & Dohme LLC | 2010-02-01 |
| Trial of a Treatment Algorithm for the Management of Crohn's Disease (NCT01030809) | University of Western Ontario, Canada | 2010-01-01 |
| Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy (NCT01053559) | Shafran Gastroenterology Center | 2010-01-01 |
| Cannabidiol for Inflammatory Bowel Disease (NCT01037322) | Meir Medical Center | 2010-01-01 |
| Cannabis for Inflammatory Bowel Disease (NCT01040910) | Meir Medical Center | 2010-01-01 |
| Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease (NCT01288053) | Northwestern University | 2010-01-01 |
| PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's Disease (NCT01051622) | GlaxoSmithKline | 2010-01-01 |
| The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease (NCT01548014) | Samsung Medical Center | 2010-01-01 |
| CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease (NCT01183403) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2010-01-01 |
| MRI-Based Screening in a Retrospective Cohort Reveals Adverse Prognosis of Asymptomatic Perianal Fistulas in Crohn's Disease: A Long-term Follow-Up Study (NCT07555808) | Sixth Affiliated Hospital, Sun Yat-sen University | 2010-01-01 |
| Study About the Effect of Doxycycline and Acetylcystein in the Treatment of CD-associated Fistulae (NCT01012726) | Gerhard Rogler | 2009-11-01 |
| Efficacy Study of T2 Versus AZA to Maintain Clinical and Endoscopic Remission in Postoperative Crohn's Disease (NCT01015391) | Jinling Hospital, China | 2009-11-01 |
| 9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease (NCT01086553) | Dr. Falk Pharma GmbH | 2009-11-01 |
| Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease (NCT01074580) | Haukeland University Hospital | 2009-11-01 |
| An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease (NCT01009281) | Novartis Pharmaceuticals | 2009-10-30 |
| Endomicroscopy and Crohn´s Disease (NCT01102855) | University of Erlangen-Nürnberg Medical School | 2009-10-01 |
| Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy (NCT01661257) | Samsung Medical Center | 2009-10-01 |
| Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care (NCT01296841) | VA Palo Alto Health Care System | 2009-10-01 |
| A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease (NCT00989573) | Otsuka Pharmaceutical Co., Ltd. | 2009-10-01 |
| Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice (NCT02322008) | Regionshospitalet Viborg, Skive | 2009-09-01 |
| The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients (NCT01012570) | Gerhard Rogler | 2009-08-01 |
| VSL#3 Treatment in Children With Crohn's Disease (NCT00367705) | Hadassah Medical Organization | 2009-08-01 |
| Exacerbating Factors in Inflammatory Bowel Disease (NCT01405105) | Dallas VA Medical Center | 2009-08-01 |
| Post-operative Crohn's Endoscopic Recurrence Study (NCT00989560) | University of Melbourne | 2009-08-01 |
| Microparticles in Pediatric Inflammatory Disease (NCT00979485) | Indiana University | 2009-08-01 |
| NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease (NCT00936585) | National Institutes of Health Clinical Center (CC) | 2009-07-01 |
| Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease (NCT00972218) | University of Alberta | 2009-07-01 |
| Single Ascending Dose Study of Oral CPSI-2364 (Semapimod) (NCT00950105) | Ferring Pharmaceuticals | 2009-07-01 |
| Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease (NCT01277289) | Quince Therapeutics S.p.A. | 2009-06-03 |
| Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease. (NCT01372969) | Tigenix S.A.U. | 2009-06-01 |
| An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen (NCT00917514) | Medicpen AB | 2009-06-01 |
| Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy (NCT00851565) | Copenhagen University Hospital at Herlev | 2009-06-01 |
| An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease (NCT00790933) | Takeda | 2009-05-22 |
| Detecting Postoperative Recurrence in Crohn's Disease (NCT00886327) | Johann Wolfgang Goethe University Hospital | 2009-05-01 |
| Curcumin in Pediatric Inflammatory Bowel Disease (NCT00889161) | Seattle Children's Hospital | 2009-05-01 |
| A Study With Pentasa in Patients With Active Crohn's Disease (NCT00862121) | Ferring Pharmaceuticals | 2009-04-01 |
| The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents (NCT00899678) | UCB Celltech | 2009-04-01 |
| Intestinal Wall Remodeling (Infliximab Therapy) in Crohn's Disease Patients Undergoing Serial Computed Tomography (CT) Enterography (NCT00819663) | Mayo Clinic | 2009-02-01 |
| The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease" (NCT00245505) | Ferring Pharmaceuticals | 2009-02-01 |
| Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease (NCT00780949) | Assistance Publique - Hôpitaux de Paris | 2009-01-01 |
| Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD) (NCT00805766) | Tanabe Pharma Corporation | 2008-12-01 |
| A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy (NCT00771667) | Centocor, Inc. | 2008-12-01 |
| Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy (NCT00801125) | Biogen | 2008-12-01 |
| Induction of Clinical Response Using Rifaximin in Crohn's Disease (NCT00603616) | Scott Lee | 2008-11-01 |
| Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease (NCT00790543) | Emory University | 2008-11-01 |
| Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease (NCT00808262) | Neovacs | 2008-10-01 |
| The Effect of Infliximab on Sperm Quality (NCT00745329) | Tel-Aviv Sourasky Medical Center | 2008-10-01 |
| FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR (NCT00810030) | Vifor Pharma | 2008-10-01 |
| Thalidomide in Pediatric Inflammatory Bowel Diseases. (NCT00720538) | IRCCS Burlo Garofolo | 2008-08-01 |
| Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease (NCT00584740) | Novartis Pharmaceuticals | 2008-08-01 |
| Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population (NCT00815061) | Rabin Medical Center | 2008-07-01 |
| The Effect of Vitamin K Supplementation on Bone Health in Adult Crohn's Disease Patients (NCT01235325) | University College Cork | 2008-07-01 |
| The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease (NCT00715117) | Milton S. Hershey Medical Center | 2008-07-01 |
| CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring (NCT00707512) | Biogen | 2008-06-30 |
| Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease (NCT00769236) | Assistance Publique Hopitaux De Marseille | 2008-06-01 |
| Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease (NCT00609973) | University of North Carolina, Chapel Hill | 2008-05-01 |
| Study to Determine Relationship Between Serum Infliximab and Efficacy in Luminal Crohn's Disease Patients (NCT00676988) | University of Western Ontario, Canada | 2008-05-01 |
| Bronchial Hyperreactivity in Children With Crohn Disease (NCT01297907) | Rambam Health Care Campus | 2008-05-01 |
| Growth Relapse and Outcomes With Therapy 1 (NCT00711945) | European Society of Pediatric Gastroenterology, Hepatology and Nutrition | 2008-03-01 |
| Vitamin D Levels in Children With IBD (NCT00621257) | Boston Children's Hospital | 2008-01-01 |
| A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease (NCT00615199) | Pfizer | 2008-01-01 |
| Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD) (NCT02185183) | Hadassah Medical Organization | 2008-01-01 |
| Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness (NCT00769353) | University of Pittsburgh | 2008-01-01 |
| Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease (NCT00619489) | Millennium Pharmaceuticals, Inc. | 2007-12-01 |
| A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease (NCT00358683) | UCB Pharma | 2007-11-01 |
| Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease (NCT00562887) | Abbott | 2007-11-01 |
| Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease (NCT00792740) | Italfarmaco | 2007-10-22 |
| A Comparative Study of Capsule Endoscopy, Magnetic Resonance Imaging and Computer Tomography Scanning of the Small Bowel in Crohn's Disease (NCT01019460) | University of Southern Denmark | 2007-10-01 |
| Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease (NCT00543374) | Mesoblast, Inc. | 2007-09-17 |
| Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease (NCT00482092) | Mesoblast, Inc. | 2007-09-17 |
| Managing Inflammatory Bowel Disease (NCT00679003) | University of Washington | 2007-09-01 |
| Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease (NCT00528073) | Alfasigma S.p.A. | 2007-09-01 |
| A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD) (NCT00524537) | AbbVie (prior sponsor, Abbott) | 2007-09-01 |
| Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease (NCT00487396) | Medtronic - MITG | 2007-09-01 |
| Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity (NCT00496548) | Vanderbilt University Medical Center | 2007-08-01 |
| Can CT Enteroclysis Predict the Outcome of Crohn's Disease (NCT00572780) | Indiana University | 2007-08-01 |
| Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis (NCT00586599) | Indiana University | 2007-08-01 |
| Post Marketing Surveillance of Remicade (NCT00724529) | Janssen Korea, Ltd., Korea | 2007-06-01 |